查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
放射腫瘤學市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按類型、應用和地理位置
市場調查報告書
商品編碼
1558381

放射腫瘤學市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按類型、應用和地理位置

Radiation Oncology Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, and Geography
出版日期: | 出版商: The Insight Partners | 英文 170 Pages | 訂單完成後即時交付

價格

依據「2031 年放射腫瘤學市場預測 - 全球分析 - 按類型、應用和地理位置」的新研究，該市場預計將從 2023 年的 8,924.44 百萬美元成長到 2023 年達到 23,620.56 百萬美元。 ；預計 2023-2031 年複合年成長率為 13.0%。放射腫瘤學市場的成長歸因於癌症盛行率的增加以及支持放射腫瘤學發展的措施的激增。放射腫瘤學市場參與者的策略性舉措可能會為市場成長提供機會。放射腫瘤學市場報告強調了推動市場的關鍵因素，並展示了知名參與者的發展。

放射治療或放射治療是一種常見的癌症治療方法，它使用放射（通常是高能量 X 光）來殺死癌細胞。放射治療可以單獨使用，也可以與其他治療一起使用，例如手術或化療。放射腫瘤科醫師是專門從事放射治療的醫療保健提供者。

2023年，北美在全球放射腫瘤學市場中佔據主要佔有率。在美國，所有癌症患者都可以廣泛使用放射治療，並且對放射腫瘤科醫師的需求不斷增加。由於醫療保健基礎設施的發達，這些專業人員的數量也不斷增加。儘管如此，美國臨床腫瘤學會估計全球約三分之二的癌症患者接受放射治療作為治療的一部分。到 2022 年，預計美國每年將有超過 100 萬名癌症患者接受放射治療。政府和醫療機構正在採取多項措施來鼓勵採用放射治療。 2020 年 6 月，美國放射腫瘤學會 (ASTRO) 推出了非轉移性子宮頸癌放射治療的新臨床指南。新指南的重點是精確實施放射治療的步驟和流程。加拿大放射腫瘤學協會 (CARO) 制定了有關放射腫瘤學的具體指南。 《日本臨床腫瘤學雜誌》發表的一項研究報告稱，安大略省每年有近 35,000 名患者接受放射治療，約佔該省癌症患者的 39%。加拿大以人口為基礎的單一付款人癌症系統不斷變化，以提高獲取機會、診斷品質、治療結果和支持。它也很好地定位了放射治療，確保人們有足夠的機會獲得這種治療。儘管如此，獲得治療的情況需要密切監測。隨著人口老化和技術進步，加拿大計劃繼續創新、開展研究並改變放射腫瘤學的實踐。癌症發生率上升、政府措施和技術進步是推動墨西哥放射腫瘤學市場成長的幾個因素。該國特別記錄了肺癌、前列腺癌和乳腺癌的高發生率，導致對有效治療的放射治療的需求增加。墨西哥政府致力於吸引大量外國投資和國際參與者。例如，2018 年，Elekta 收到了墨西哥政府提供放射治療系統的招標。據估計，此類合作將在預測期內推動墨西哥放射腫瘤學市場的發展。

放射腫瘤學的策略性措施為未來提供市場機會

放射腫瘤學在癌症治療上具有巨大的潛力。此外，市場參與者在產品開發、創新、產品發布、產品批准、合併、收購和合作夥伴關係等方面不斷發展放射治療預計將有助於市場成長。市場上最近採取的一些策略性舉措是

2024 年 5 月，Elekta 推出了最新的直線加速器 (linac) Evo，這是一款具有新型高清 AI 增強成像的 CT-Linac，能夠提供離線和線上自適應放射治療以及改進的標準影像引導放射治療。

2024 年 5 月，The Icon Group 與 Cyber​​knife Australia Pty Ltd 合作建立多達 6 家新的放射腫瘤診所（擬成立合資企業），將使用「Cyber​​knife」系統提供放射腫瘤治療。

2024 年5 月，GE HealthCare 推出了Revolution RT，這是一種新型放射治療電腦斷層掃描(CT) 解決方案，具有創新的硬體和軟體解決方案，有助於提高成像準確性，同時簡化模擬工作流程，為臨床醫生和患者提供更個人化和無縫的腫瘤護理路徑體驗。

2024 年4 月，Accuray Incorporated 在ESTRO 2024 上展示了旨在改善癌症治療體驗的硬體和軟體的進步。所需的技術。

2023年10月，CIVCO放射治療與Qfix推出新品牌CQ Medical。該公司專注於改善癌症護理和患者治療結果，並與臨床醫生和技術合作夥伴在該領域進行深入合作。

2023 年 9 月，MVision AI 推出了第一個全面的基於指南的分割 (GBS) 解決方案，用於有效的放射治療輪廓繪製。 Guide 有助於臨床團隊準確評估人工智慧生成的結構，從而使他們能夠提高輪廓繪製技能。驗證可以對輪廓進行視覺和體積比較，方便診所觀察相似點和差異。 Guide verify 和 Contour+ 的組合實施涵蓋了放射治療輪廓的所有臨床需求。

因此，放射腫瘤學市場的市場參與者的策略性舉措不斷湧現，預計將放大市場成長並為放射腫瘤學市場創造充足的機會。

放射腫瘤學市場：競爭格局與主要發展

Varian Medical Systems Inc、Elekta AB、Accuracy Incorporated、IBA Worldwide (Ion Beam Applications SA)、Becton Dickinson & Co、Perspective Therapeutics Inc、Nordion、Mevion Medical Systems、NTP Radioisotopes 和 Mallinckrodt Plc。是放射腫瘤市場的主要公司之一。

美國食品藥物管理局、疾病管制與預防中心 (CDC) 和美國放射腫瘤學會是準備放射腫瘤學市場報告時提到的主要和次要來源之一。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第 4 章：放射腫瘤學市場格局

  • 概述
  • PEST分析

第 5 章：放射腫瘤學市場 - 主要市場動態

  • 放射腫瘤學市場 - 主要市場動態
  • 市場促進因素：
    • 癌症盛行率增加
    • 支持放射腫瘤學發展的舉措
  • 市場限制
    • 放射治療設備成本高
  • 市場機會
    • 放射腫瘤學的策略性舉措
  • 未來趨勢
    • 放射腫瘤學的技術進步
  • 促進因素和限制的影響：

第 6 章：放射腫瘤學市場 - 全球市場分析

  • 放射腫瘤學市場收入，2021-2031

第 7 章：放射腫瘤學市場分析 - 按類型

  • 外束放射治療
  • 內束放射治療

第 8 章：放射腫瘤學市場分析 - 按應用

  • 乳癌
  • 攝護腺癌
  • 肺癌
  • 頭頸癌
  • 子宮頸癌
  • 其他

第 9 章：放射腫瘤學市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 10 章：放射腫瘤學市場 - 產業格局

  • 概述
  • 放射腫瘤學市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 11 章：公司簡介

  • Varian Medical Systems Inc
  • Elekta AB
  • Accuray Incorporated
  • IBA Worldwide (Ion Beam Applications SA)
  • Becton Dickinson and Co
  • Perspective Therapeutics Inc
  • Nordion
  • Mevion Medical Systems
  • NTP RADIOISOTOPES
  • Mallinckrodt Plc
  • Provision Healthcare
  • Panacea Medical Technologies Pvt. Ltd
  • Curium

第 12 章：附錄

Product Code: TIPRE00004195

According to our new research study on "Radiation Oncology Market Forecast to 2031 -Global Analysis - by Type, Application, and Geography," the market is anticipated to grow from US$ 8,924.44 million in 2023 and is projected to reach US$ 23,620.56 million by 2031; it is expected to register a CAGR of 13.0% during 2023-2031. The radiation oncology market growth is attributed to the increasing prevalence of cancer and surging initiatives to support developments in radiation oncology. Strategic initiatives by radiation oncology market players are likely to offer opportunities for market growth. The radiation oncology market report emphasizes the key factors driving the market and showcases the developments of prominent players.

Radiation therapy or radiotherapy is a common cancer treatment that uses radiation (usually high-powered X-rays) to kill cancer cells. Radiation therapy may be used independently or alongside other treatments, like surgery or chemotherapy. Radiation oncologists are healthcare providers who specialize in radiation therapy.

North America accounted for a major share of the global radiation oncology market in 2023. The North America radiation oncology market is segmented into the US, Canada, and Mexico. Radiation therapy is widely available for all cancer patients in the US, and the need for radiation oncologists is continuously on the rise. The number of these professionals also increases continuously owing to the developed healthcare infrastructure. Nevertheless, the American Society of Clinical Oncology approximately two-thirds of cancer patients globally are estimated to receive radiation therapy as a part of their treatment. In 2022, over 1 million cancer patients in the US are projected to undergo radiation therapy annually. The government and healthcare authorities are taking several initiatives to encourage the adoption of radiotherapy. In June 2020, the American Society for Radiation Oncology (ASTRO) introduced new clinical guidelines regarding radiotherapy for nonmetastatic cervical cancer. The new guidelines focus on precisely implementing steps and processes to conduct radiation therapy. The Canadian Association of Radiation Oncology (CARO) has established specific guidelines about radiation oncology. A study published in the Japanese Journal of Clinical Oncology reports that nearly 35,000 patients in Ontario receive radiation therapy annually, accounting for ~39% of cancer patients in the province. Canada's population-based, single-payer cancer system constantly changes to enhance access, diagnosis quality, treatment outcomes, and support. It has also positioned radiotherapy well, ensuring that people have sufficient access to this treatment. Nonetheless, access to the treatment needs close monitoring. Canada plans to continue to innovate, conduct research, and change the practice of radiation oncology as its population ages and technology advances. Rising cancer incidence, government initiatives, and technology improvements are a few factors driving growth of the radiation oncology market in Mexico. The country specifically records high incidences of lung, prostate, and breast cancer, resulting in an elevated demand for radiation therapy for effective treatment. The government of Mexico focuses on attracting significant foreign investments and international players. For instance, in 2018, Elekta received a tender from the government of Mexico to deliver radiation therapy systems. Such collaborations are estimated to boost the Mexico radiation oncology market during the forecast period.

Strategic Initiatives in Radiation Oncology to Provide Market Opportunities in Future

Radiation oncology holds tremendous potential in cancer treatment. Additionally, constant evolution in radiotherapy by the market players in terms of product development, innovation, product launch, product approval, merger, acquisition and partnerships, and others is expected to contribute the market growth. Some of the recent strategic initiatives taken place in the market are

In May 2024, Elekta launched its latest linear accelerator (linac), Evo, a CT-Linac with new high-definition AI enhanced imaging, capable of delivering offline and online adaptive radiation therapy as well as improved standard image-guided radiation therapy treatments.

In May 2024, The Icon Group collaborated with Cyberknife Australia Pty Ltd to establish up to 6 new radiation oncology clinics (proposed joint venture), which will provide radiation oncology treatments using the 'Cyberknife' system.

In May 2024, GE HealthCare launched Revolution RT, a new radiation therapy computed tomography (CT) solution with innovative hardware and software solutions to help increase imaging accuracy, while simplifying simulation workflow for a more personalized and seamless oncology care pathway experience for clinicians and patients.

In April 2024, Accuray Incorporated showcased advancement in hardware and software designed to improve the cancer treatment experience, at ESTRO 2024. The latest generation CyberKnife and Radixact platforms provide medical care teams with the technology necessary for expanding the curative power of radiation therapy and delivering on the focus of this year's congress, bridging the care gap.

In October 2023, CIVCO Radiotherapy and Qfix launched a new brand CQ Medical. The company focuses on the improvement of cancer care and patient outcome along with deep engagement in the field with clinicians and technology partners.

In September 2023, MVision AI launched the first comprehensive Guideline-Based Segmentation (GBS) solution for effective radiation therapy contouring. Guide facilitates clinical teams to accurately evaluate AI-generated structures, thus enabling them to refine their contouring skills. Verify allows visual and volumetric comparison of contours, facilitating clinics to observe similarities and differences. The combined implementation of Guide Verify and Contour+ encompasses all clinical needs in radiotherapy contouring.

Therefore, surging strategic initiatives among market players operating in radiation oncology market which are expected to amplify the market growth and create ample opportunities for the radiation oncology market.

Radiation Oncology Market: Competitive Landscape and Key Developments

Varian Medical Systems Inc, Elekta AB, Accuracy Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson & Co, Perspective Therapeutics Inc, Nordion, Mevion Medical Systems, NTP Radioisotopes, and Mallinckrodt Plc. are among the key companies operating in the radiation oncology market.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and American Society for Radiation Oncology are among the primary and secondary sources referred to while preparing the radiation oncology market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Radiation Oncology Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis

5. Radiation Oncology Market - Key Market Dynamics

  • 5.1 Radiation Oncology Market - Key Market Dynamics
  • 5.2 Market Drivers:
    • 5.2.1 Increasing Prevalence of Cancer
    • 5.2.2 Initiatives to Support Developments in Radiation Oncology
  • 5.3 Market Restraints
    • 5.3.1 High Cost of Radiotherapy Equipment
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives in Radiation Oncology
  • 5.5 Future Trends
    • 5.5.1 Technological Advancement in Radiation Oncology
  • 5.6 Impact of Drivers and Restraints:

6. Radiation Oncology Market - Global Market Analysis

  • 6.1 Radiation Oncology Market Revenue (US$ Million), 2021-2031

7. Radiation Oncology Market Analysis - by Types

  • 7.1 External Beam Radiation Therapy
    • 7.1.1 Overview
    • 7.1.2 External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Internal Beam Radiation Therapy
    • 7.2.1 Overview
    • 7.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

8. Radiation Oncology Market Analysis - by Application

  • 8.1 Breast Cancer
    • 8.1.1 Overview
    • 8.1.2 Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Prostate Cancer
    • 8.2.1 Overview
    • 8.2.2 Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Lung Cancer
    • 8.3.1 Overview
    • 8.3.2 Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Head and Neck Cancer
    • 8.4.1 Overview
    • 8.4.2 Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Cervical Cancer
    • 8.5.1 Overview
    • 8.5.2 Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)

9. Radiation Oncology Market - Geographical Analysis

  • 9.1 North America
    • 9.1.1 North America Radiation Oncology Market Overview
    • 9.1.2 North America: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.1.2.1 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
      • 9.1.2.2 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
      • 9.1.2.3 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
      • 9.1.2.4 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
    • 9.1.3 North America: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 9.1.3.1 United States: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.3.1.1 United States: Radiation Oncology Market Breakdown, by Types
        • 9.1.3.1.2 United States: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.1.3.1.3 United States: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.1.3.1.4 United States: Radiation Oncology Market Breakdown, by Application
      • 9.1.3.2 Canada: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.3.2.1 Canada: Radiation Oncology Market Breakdown, by Types
        • 9.1.3.2.2 Canada: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.1.3.2.3 Canada: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.1.3.2.4 Canada: Radiation Oncology Market Breakdown, by Application
      • 9.1.3.3 Mexico: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.3.3.1 Mexico: Radiation Oncology Market Breakdown, by Types
        • 9.1.3.3.2 Mexico: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.1.3.3.3 Mexico: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.1.3.3.4 Mexico: Radiation Oncology Market Breakdown, by Application
  • 9.2 Europe
    • 9.2.1 Europe Radiation Oncology Market Overview
    • 9.2.2 Europe: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.2.2.1 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
      • 9.2.2.2 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
      • 9.2.2.3 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
      • 9.2.2.4 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
    • 9.2.3 Europe: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 9.2.3.1 Germany: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.1.1 Germany: Radiation Oncology Market Breakdown, by Types
        • 9.2.3.1.2 Germany: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.2.3.1.3 Germany: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.2.3.1.4 Germany: Radiation Oncology Market Breakdown, by Application
      • 9.2.3.2 United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.2.1 United Kingdom: Radiation Oncology Market Breakdown, by Types
        • 9.2.3.2.2 United Kingdom: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.2.3.2.3 United Kingdom: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.2.3.2.4 United Kingdom: Radiation Oncology Market Breakdown, by Application
      • 9.2.3.3 France: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.3.1 France: Radiation Oncology Market Breakdown, by Types
        • 9.2.3.3.2 France: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.2.3.3.3 France: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.2.3.3.4 France: Radiation Oncology Market Breakdown, by Application
      • 9.2.3.4 Spain: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.4.1 Spain: Radiation Oncology Market Breakdown, by Types
        • 9.2.3.4.2 Spain: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.2.3.4.3 Spain: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.2.3.4.4 Spain: Radiation Oncology Market Breakdown, by Application
      • 9.2.3.5 Italy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.5.1 Italy: Radiation Oncology Market Breakdown, by Types
        • 9.2.3.5.2 Italy: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.2.3.5.3 Italy: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.2.3.5.4 Italy: Radiation Oncology Market Breakdown, by Application
      • 9.2.3.6 Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.3.6.1 Rest of Europe: Radiation Oncology Market Breakdown, by Types
        • 9.2.3.6.2 Rest of Europe: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.2.3.6.3 Rest of Europe: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.2.3.6.4 Rest of Europe: Radiation Oncology Market Breakdown, by Application
  • 9.3 Asia Pacific
    • 9.3.1 Asia Pacific Radiation Oncology Market Overview
    • 9.3.2 Asia Pacific: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.3.2.1 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
      • 9.3.2.2 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
      • 9.3.2.3 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
      • 9.3.2.4 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
    • 9.3.3 Asia Pacific: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 9.3.3.1 China: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.1.1 China: Radiation Oncology Market Breakdown, by Types
        • 9.3.3.1.2 China: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.3.3.1.3 China: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.3.3.1.4 China: Radiation Oncology Market Breakdown, by Application
      • 9.3.3.2 Japan: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.2.1 Japan: Radiation Oncology Market Breakdown, by Types
        • 9.3.3.2.2 Japan: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.3.3.2.3 Japan: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.3.3.2.4 Japan: Radiation Oncology Market Breakdown, by Application
      • 9.3.3.3 India: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.3.1 India: Radiation Oncology Market Breakdown, by Types
        • 9.3.3.3.2 India: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.3.3.3.3 India: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.3.3.3.4 India: Radiation Oncology Market Breakdown, by Application
      • 9.3.3.4 Australia: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.4.1 Australia: Radiation Oncology Market Breakdown, by Types
        • 9.3.3.4.2 Australia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.3.3.4.3 Australia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.3.3.4.4 Australia: Radiation Oncology Market Breakdown, by Application
      • 9.3.3.5 South Korea: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.5.1 South Korea: Radiation Oncology Market Breakdown, by Types
        • 9.3.3.5.2 South Korea: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.3.3.5.3 South Korea: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.3.3.5.4 South Korea: Radiation Oncology Market Breakdown, by Application
        • 9.3.3.5.5 Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.3.5.6 Rest of APAC: Radiation Oncology Market Breakdown, by Types
        • 9.3.3.5.7 Rest of APAC: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.3.3.5.8 Rest of APAC: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.3.3.5.9 Rest of APAC: Radiation Oncology Market Breakdown, by Application
  • 9.4 Middle East and Africa
    • 9.4.1 Middle East and Africa Radiation Oncology Market Overview
    • 9.4.2 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.4.2.1 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
      • 9.4.2.2 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
      • 9.4.2.3 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
      • 9.4.2.4 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
    • 9.4.3 Middle East and Africa: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 9.4.3.1 Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.3.1.1 Saudi Arabia: Radiation Oncology Market Breakdown, by Types
        • 9.4.3.1.2 Saudi Arabia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.4.3.1.3 Saudi Arabia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.4.3.1.4 Saudi Arabia: Radiation Oncology Market Breakdown, by Application
      • 9.4.3.2 South Africa: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.3.2.1 South Africa: Radiation Oncology Market Breakdown, by Types
        • 9.4.3.2.2 South Africa: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.4.3.2.3 South Africa: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.4.3.2.4 South Africa: Radiation Oncology Market Breakdown, by Application
      • 9.4.3.3 United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.3.3.1 United Arab Emirates: Radiation Oncology Market Breakdown, by Types
        • 9.4.3.3.2 United Arab Emirates: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.4.3.3.3 United Arab Emirates: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.4.3.3.4 United Arab Emirates: Radiation Oncology Market Breakdown, by Application
      • 9.4.3.4 Rest of Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.3.4.1 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by Types
        • 9.4.3.4.2 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.4.3.4.3 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.4.3.4.4 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by Application
  • 9.5 South and Central America
    • 9.5.1 South and Central America Radiation Oncology Market Overview
    • 9.5.2 South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.5.2.1 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by Types
      • 9.5.2.2 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by External Beam Radiation Therapy
      • 9.5.2.3 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by Internal Beam Radiation Therapy
      • 9.5.2.4 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by Application
    • 9.5.3 South and Central America: Radiation Oncology Market - Revenue and Forecast Analysis - by Country
      • 9.5.3.1 Brazil: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.3.1.1 Brazil: Radiation Oncology Market Breakdown, by Types
        • 9.5.3.1.2 Brazil: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.5.3.1.3 Brazil: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.5.3.1.4 Brazil: Radiation Oncology Market Breakdown, by Application
      • 9.5.3.2 Argentina: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.3.2.1 Argentina: Radiation Oncology Market Breakdown, by Types
        • 9.5.3.2.2 Argentina: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.5.3.2.3 Argentina: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.5.3.2.4 Argentina: Radiation Oncology Market Breakdown, by Application
      • 9.5.3.3 Rest of South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.3.3.1 Rest of South and Central America: Radiation Oncology Market Breakdown, by Types
        • 9.5.3.3.2 Rest of South and Central America: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
        • 9.5.3.3.3 Rest of South and Central America: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
        • 9.5.3.3.4 Rest of South and Central America: Radiation Oncology Market Breakdown, by Application

10. Radiation Oncology Market - Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in Radiation Oncology Market
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Inorganic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Varian Medical Systems Inc
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview (Siemens Healthineers AG)
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Elekta AB
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Accuray Incorporated
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 IBA Worldwide (Ion Beam Applications SA)
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Becton Dickinson and Co
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Perspective Therapeutics Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Nordion
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Mevion Medical Systems
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 NTP RADIOISOTOPES
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Mallinckrodt Plc
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 Provision Healthcare
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Products and Services
    • 11.11.4 Financial Overview
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments
  • 11.12 Panacea Medical Technologies Pvt. Ltd
    • 11.12.1 Key Facts
    • 11.12.2 Business Description
    • 11.12.3 Products and Services
    • 11.12.4 Financial Overview
    • 11.12.5 SWOT Analysis
    • 11.12.6 Key Developments
  • 11.13 Curium
    • 11.13.1 Key Facts
    • 11.13.2 Business Description
    • 11.13.3 Products and Services
    • 11.13.4 Financial Overview
    • 11.13.5 SWOT Analysis
    • 11.13.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. Radiation Oncology Market Segmentation
  • Table 2. North America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 3. North America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 4. North America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 5. North America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 6. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 7. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 8. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 9. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 10. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 11. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 12. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 13. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 14. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 15. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 16. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 17. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 18. Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 19. Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 20. Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 21. Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 22. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 23. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 24. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 25. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 26. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 27. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 28. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 29. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 30. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 31. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 32. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 33. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 34. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 35. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 36. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 37. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 38. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 39. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 40. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 41. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 42. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 43. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 44. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 45. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 46. Asia Pacific: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 47. Asia Pacific: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 48. Asia Pacific: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 49. Asia Pacific: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 50. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 51. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 52. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 53. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 54. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 55. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 56. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 57. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 58. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 59. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 60. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 61. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 62. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 63. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 64. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 65. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 66. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 67. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 68. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 69. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 70. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 71. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 72. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 73. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 74. Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 75. Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 76. Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 77. Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 78. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 79. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 80. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 81. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 82. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 83. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 84. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 85. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 86. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 87. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 88. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 89. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 90. Rest of Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 91. Rest of Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 92. Rest of Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 93. Rest of Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 94. South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 95. South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 96. South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 97. South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 98. Brazil: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 99. Brazil: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 100. Brazil: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 101. Brazil: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 102. Argentina: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 103. Argentina: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 104. Argentina: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 105. Argentina: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 106. Rest of South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Types
  • Table 107. Rest of South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by External Beam Radiation Therapy
  • Table 108. Rest of South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Internal Beam Radiation Therapy
  • Table 109. Rest of South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 110. Recent Organic Growth Strategies in Radiation Oncology Market
  • Table 111. Recent Inorganic Growth Strategies in the Radiation Oncology Market
  • Table 112. Glossary of Terms, Radiation Oncology Market

List Of Figures

  • Figure 1. Radiation Oncology Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Statistics at Glance, Global, 2022
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Radiation Oncology Market Revenue (US$ Million), 2021-2031
  • Figure 6. Radiation Oncology Market Share (%) - by Types (2023 and 2031)
  • Figure 7. External Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Internal Beam Radiation Therapy: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Radiation Oncology Market Share (%) - by Application (2023 and 2031)
  • Figure 10. Breast Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Prostate Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Lung Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Head and Neck Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Cervical Cancer: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Others: Radiation Oncology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. North America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 17. North America: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 18. United States: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 19. Canada: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 20. Mexico: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 21. Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 22. Europe: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 23. Germany: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 24. United Kingdom: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 25. France: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 26. Spain: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 27. Italy: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 28. Rest of Europe: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 29. Asia Pacific: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 30. Asia Pacific: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 31. China: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 32. Japan: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 33. India: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 34. Australia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 35. South Korea: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 36. Rest of APAC: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 37. Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 38. Middle East and Africa: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 39. Saudi Arabia: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 40. South Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 41. United Arab Emirates: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 42. Rest of Middle East and Africa: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 43. South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 44. South and Central America: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 45. Brazil: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 46. Argentina: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 47. Rest of South and Central America: Radiation Oncology Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 48. Growth Strategies in Radiation Oncology Market